Avalo Therapeutics, Inc. (AVTX) vs Geron Corporation (GERN)
A side-by-side comparison of Avalo Therapeutics, Inc. and Geron Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVTX
Avalo Therapeutics, Inc.
$13.53HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
GERN
Geron Corporation
$1.22HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — AVTX vs GERN
growth of $100 · dividends reinvested · last 10yAVTX -99.9% (-48.7%/yr)GERN -46.7% (-6.1%/yr)GERN compounded faster over this window
Log scale — wide-divergence pair
AVTX GERN
AVTX vs GERN: by the numbers
- •GERN is the larger company ($779M vs $711M market cap).
- •Both run net losses; GERN's is the smaller (-34.17% vs -170055.93% net margin).
- •GERN grew revenue faster over the past five years (247.85% vs -60.88% CAGR).
Metrics side by side
Valuation
| Metric | AVTX | GERN |
|---|---|---|
| P/S ratio | 12054.45 | 3.81 |
| P/B ratio | 1.59 | 3.57 |
Profitability
| Metric | AVTX | GERN |
|---|---|---|
| Gross margin | 100.00% | 97.42% |
| Operating margin | -123601.69% | -29.28% |
| Net margin | -170055.93% | -34.17% |
| ROE | -22.36% | -31.97% |
| ROIC | -19.45% | -8.34% |
Growth (annualized)
| Metric | AVTX | GERN |
|---|---|---|
| Revenue CAGR (5Y) | -60.88% | 247.85% |
| Total return CAGR (5Y) | -70.04% | -1.87% |
Frequently asked
- Which has grown faster, AVTX or GERN?
- Over the past five years, GERN grew revenue faster — AVTX at a -60.88% CAGR versus GERN at 247.85%.
- How have AVTX and GERN total returns compared?
- Over the past 10 years, AVTX delivered -48.70% and GERN delivered -6.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Avalo Therapeutics ROEGeron ROEAvalo Therapeutics operating marginGeron operating marginAvalo Therapeutics revenue growthGeron revenue growthAvalo Therapeutics free cash flowGeron free cash flow
Avalo Therapeutics & Geron appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.